Mandate

Vinge advises Industrifonden

May 29, 2013

Vinge has advised Industrifonden in connection with Flexenclosure’s capital raising. The company has secured an investment of SEK 160 million, half of which has been provided by IFC (International Finance Corporation) and the other by the former owners, Industrifonden and AP 2. The new capital will be used to accelerate sales and further develop Flexenclosure’s “green” telecom and IT solutions, primarily eSite and eCentre.

Flexenclosure has an aggressive research and development programme and is expanding its sales operations in emerging markets. During the last year, the company has opened offices in Nigeria, Kenya, Pakistan, India, Malaysia and Dubai. 

Vinge partner Johan Larsson advised Industrifonden.

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026